Clinical response and pharmacokinetics of bendamustine as a component of salvage R-B(O)AD therapy for the treatment of primary central nervous system lymphoma (PCNSL)-Reference-Cited by-同舟云学术

Clinical response and pharmacokinetics of bendamustine as a component of salvage R-B(O)AD therapy for the treatment of primary central nervous system lymphoma (PCNSL)

Published:2018-07-09 Issue:1 Volume:18 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Kim Therasa,Choi He Yun,Lee Hyun-Seo,Jung Sung-Hoon,Ahn Jae-Sook,Kim Hyeoung-Joon,Lee Je-Jung,Yoo Hee-Doo,Yang Deok-Hwan

Funder

Chonnam National University (KR) Hwasun Hospital

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-018-4632-y.pdf

Reference36 articles.

1. Villano JL, Koshy M, Shaikh H, Dolecek TA, McCarthy BJ. Age, gender, and racial differences in incidence and survival in primary CNS lymphoma. Br J Cancer. 2011;105(9):1414–8.

2. Dolecek TA, Propp JM, Stroup NE, Kruchko C. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro-Oncology. 2012;14(Suppl 5):v1–49.

3. Hoang-Xuan K, Bessell E, Bromberg J, Hottinger AF, Preusser M, Ruda R, Schlegel U, Siegal T, Soussain C, Abacioglu U, et al. Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology. Lancet Oncol. 2015;16(7):e322–32.

4. Jahnke K, Thiel E, Martus P, Herrlinger U, Weller M, Fischer L, Korfel A. Relapse of primary central nervous system lymphoma: clinical features, outcome and prognostic factors. J Neuro-Oncol. 2006;80(2):159–65.

5. Plotkin SR, Betensky RA, Hochberg FH, Grossman SA, Lesser GJ, Nabors LB, Chon B, Batchelor TT. Treatment of relapsed central nervous system lymphoma with high-dose methotrexate. Clin Cancer Res. 2004;10(17):5643–6.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bendamustine: a review of pharmacology, clinical use and immunological effects (Review);Oncology Reports;2022-05-03

2. Patients with marginal zone dural lymphoma successfully treated with rituximab and bendamustine: A report of two cases;Molecular and Clinical Oncology;2021-08-09

3. Synthesis of a potential bendamustine deschloro dimer impurity;Journal of Chemical Research;2020-11-24

4. Ibrutinib-based therapy for the treatment of marginal zone lymphoma with central nervous system involvement;Leukemia & Lymphoma;2020-07-10

5. How we manage Bing–Neel syndrome;British Journal of Haematology;2019-08-20